The present study showed that inhibition of GCN2 increased the protein expression of GLUT2, GCK, and PHDB in the livers of T2D mice, indicating that the reduced glycemia caused by GCN2 inhibition was due, in part, to the promotion of glucose uptake and the glycolysis pathway. Here, SLC2A2 is linked to type 2 diabetes mellitus.